Stay updated on Nivolumab in Resected Esophageal Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in Resected Esophageal Cancer Clinical Trial page.

Latest updates to the Nivolumab in Resected Esophageal Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page now lists a broader set of study locations across multiple countries and regions, expanding the geographic coverage of sites. Some locations have been reorganized or removed.SummaryDifference3%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe page now shows a new revision label 'Revision: v3.3.2' and removes the previous 'Revision: v3.3.1'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check37 days agoChange DetectedAdded new study locations (Seoul, Central Singapore, North Holland, Central Jutland) and site details (e.g., Pittsburgh PA; Aarhus N; Berlin; Amsterdam; Poznan; Songpa-gu), bringing the total locations to 204. Updated follow-up time frame to from randomization to death up to approximately 60 months.SummaryDifference0.9%

- Check44 days agoChange DetectedThe Taiwan site entry was changed from 'Tainan City, Taiwan, 70403' to 'Tainan, Taiwan, 70403'.SummaryDifference0.1%

- Check58 days agoChange DetectedNo significant additions or deletions were detected on the page; the study details, eligibility criteria, and locations appear unchanged.SummaryDifference0.1%

- Check73 days agoChange DetectedThe page now adds a verified date with a status of Active, not recruiting and includes an Unknown status, while removing the prior explicit 'Active, not recruiting' line. This alters how recruitment status is communicated.SummaryDifference0.5%

Stay in the know with updates to Nivolumab in Resected Esophageal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in Resected Esophageal Cancer Clinical Trial page.